Venrock Associates Iv L P - Net Worth and Insider Trading
Venrock Associates Iv L P Net Worth
The estimated net worth of Venrock Associates Iv L P is at least $15,015 dollars as of 2024-09-20. Venrock Associates Iv L P is the 10% Owner of Bellerophon Therapeutics Inc and owns about 429,014 shares of Bellerophon Therapeutics Inc (BLPH) stock worth over $15,015. Venrock Associates Iv L P is also the 10% Owner of Anacor Pharmaceuticals Inc and owns about 0 shares of Anacor Pharmaceuticals Inc (ANAC) stock worth over $0. Details can be seen in Venrock Associates Iv L P's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Venrock Associates Iv L P has not made any transactions after 2019-10-28 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Venrock Associates Iv L P
Venrock Associates Iv L P Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Venrock Associates Iv L P owns 6 companies in total, including Bellerophon Therapeutics Inc (BLPH) , Quantenna Communications Inc (QTNA) , and Achaogen Inc (AKAOQ) among others .
Click here to see the complete history of Venrock Associates Iv L P’s form 4 insider trades.
Insider Ownership Summary of Venrock Associates Iv L P
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2019-10-28 | 10 percent owner |
| QTNA | Quantenna Communications Inc | 2016-11-02 | 10 percent owner |
| AKAOQ | Achaogen Inc | 2014-03-17 | 10 percent owner |
 | | 2013-11-15 | 10 percent owner |
| | 2013-09-18 | 10 percent owner |
| | 2010-04-21 | 10 percent owner |
Venrock Associates Iv L P Latest Holdings Summary
Venrock Associates Iv L P currently owns a total of 2 stocks. Among these stocks, Venrock Associates Iv L P owns 429,014 shares of Bellerophon Therapeutics Inc (BLPH) as of October 28, 2019, with a value of $15,015 and a weighting of 100%. Venrock Associates Iv L P also owns 0 shares of Anacor Pharmaceuticals Inc (ANAC) as of November 15, 2013, with a value of $0 and a weighting of 0%.
Latest Holdings of Venrock Associates Iv L P
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| BLPH | Bellerophon Therapeutics Inc | 2019-10-28 | 429,014 | 0.04 | 15,015 |
| ANAC | Anacor Pharmaceuticals Inc | 2013-11-15 | 0 | 9.82 | 0 |
Holding Weightings of Venrock Associates Iv L P
Venrock Associates Iv L P Form 4 Trading Tracker
According to the SEC Form 4 filings, Venrock Associates Iv L P has made a total of 1 transactions in Bellerophon Therapeutics Inc (BLPH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Bellerophon Therapeutics Inc is the sale of 72,923 shares on October 28, 2019, which brought Venrock Associates Iv L P around $525,047.
According to the SEC Form 4 filings, Venrock Associates Iv L P has made a total of 0 transactions in Anacor Pharmaceuticals Inc (ANAC) over the past 5 years. The most-recent trade in Anacor Pharmaceuticals Inc is the sale of 150,000 shares on November 15, 2013, which brought Venrock Associates Iv L P around $2 Million.
Insider Trading History of Venrock Associates Iv L P
- 1
Venrock Associates Iv L P Trading Performance
GuruFocus tracks the stock performance after each of Venrock Associates Iv L P's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Venrock Associates Iv L P is 12.15%. GuruFocus also compares Venrock Associates Iv L P's trading performance to market benchmark return within the same time period. The performance of stocks bought by Venrock Associates Iv L P within 3 months outperforms 9 times out of 11 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Venrock Associates Iv L P's insider trading performs compared to the benchmark.
Performance of Venrock Associates Iv L P
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 20.27 | | | | | |
| Relative Return to S&P 500(%) | 20.48 | | | | | |
Venrock Associates Iv L P Ownership Network
Venrock Associates Iv L P Owned Company Details
What does Bellerophon Therapeutics Inc do?
Who are the key executives at Bellerophon Therapeutics Inc?
Venrock Associates Iv L P is the 10 percent owner of Bellerophon Therapeutics Inc. Other key executives at Bellerophon Therapeutics Inc include 10 percent owner Puissance Life Science Opportunities Fund Vi , VP of Business Operations Parag Suresh Shah , and See Remarks Martin Dekker .
Bellerophon Therapeutics Inc (BLPH) Insider Trades Summary
Over the past 18 months, Venrock Associates Iv L P made no insider transaction in Bellerophon Therapeutics Inc (BLPH). Other recent insider transactions involving Bellerophon Therapeutics Inc (BLPH) include a net sale of 694,421 shares made by Puissance Capital Fund (gp) Llc , a net sale of 1,076,841 shares made by Puissance Life Science Opportunities Fund Vi , and a net sale of 9,455 shares made by Bobae Kim .
In summary, during the past 3 months, insiders sold 0 shares of Bellerophon Therapeutics Inc (BLPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,780,717 shares of Bellerophon Therapeutics Inc (BLPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,780,717 shares.
Bellerophon Therapeutics Inc (BLPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Bellerophon Therapeutics Inc Insider Transactions
Venrock Associates Iv L P Mailing Address
Above is the net worth, insider trading, and ownership report for Venrock Associates Iv L P. You might contact Venrock Associates Iv L P via mailing address: 3340 Hillview Avenue, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
